clinical trials
Piper Sandler Lowers Engene Holdings Rating Amid Trial Concerns
Piper Sandler has downgraded Engene Holdings’ stock rating due to concerns over ongoing clinical trials, affecting investor confidence.
Erasca Shares Plummet 48% Following Patient Death in Cancer Trial
Erasca’s stock has fallen sharply by 48% following a patient’s death in a cancer drug trial, raising safety concerns about their treatment.
Innovative HER-2 Vaccine Demonstrates Promise in Antibody Treatment
The HER-2 vaccine shows promise in enhancing antibody therapy for cancer treatment.
Breakthrough Blood Pressure Treatment Offers Hope for Resistant Cases
A new blood pressure treatment has emerged, offering hope for patients who have not benefited from existing therapies.
Revolutionary Nanoparticle Treatment Offers Hope for Allergic Rhinitis
A groundbreaking nanoparticle therapy is emerging as a potential game-changer for allergic rhinitis treatment, promising improved relief and fewer side effects.